Introduction {#sec1}
============

Induced pluripotent stem cells (iPSCs) can be generated by introducing OCT4, SOX2, KLF4, and c-MYC ([@bib29; @bib28]) or other combinations of reprogramming factors ([@bib25]) into many types of mouse and human somatic cells. The understanding of its mechanism is crucial for generating high-quality iPSCs for cell therapy applications and also provides an insight into reprogramming and normal development. The reprogramming is an orderly process consisting of distinct stages, which can be distinguished by expression of specific markers, including stage-specific embryonic antigen-1 (SSEA-1), alkaline phosphatase (ALP), E-Cadherin (CDH1), and NANOG ([@bib2; @bib23; @bib26]). However, the precise molecular mechanisms behind iPSC generation remain to be elucidated.

Reprogramming mechanisms have been investigated by cell sorting a subpopulation of intermediate cells that express a specific combination of markers. These enriched cells are initially at a specific intermediate stage but continue reprogramming upon further cell culture, subsequently becoming a heterogeneous population of asynchronously reprogrammed cells ([@bib6; @bib16; @bib20; @bib30]). Alternatively, more stable cell populations, isolated during iPSC generation, were also used for mechanistic analyses ([@bib10; @bib24]). These cells show phenotypes that are intermediate between somatic cells and iPSCs, thereby yielding mechanistic insights into reprogramming. Despite their usefulness, the stable cell populations are derived from rare by-products that appear sporadically during iPSC generation and difficult to obtain reproducibly in a predictable manner.

The efficiency of reprogramming and the characteristics of iPSCs are influenced by the expression levels and stoichiometry of reprogramming factors ([@bib3; @bib12; @bib18; @bib27; @bib33]). Detailed quantitative analyses show that merely increasing the expression levels of OCT4, SOX2, KLF4, and c-MYC does not necessarily lead to higher efficiency of iPSC generation; rather, the stoichiometry of the four factors plays a greater role in the efficiency of iPSC generation ([@bib12; @bib18; @bib33]). For example, high OCT4 and low SOX2 expression levels relative to other factors tend to generate iPSCs more efficiently than equal expression levels of the four factors. In addition, the reprogramming factor stoichiometry influences the gene expression pattern ([@bib12; @bib33]) and epigenetic status of iPSCs ([@bib3]) as well as their ability to contribute to chimeric mice ([@bib3]), suggesting that the stoichiometry of reprogramming factors may impact the reprogramming process as well.

We previously developed a unique gene transfer system, named SeVdp vectors, based on a mutant strain of Sendai virus, which remains persistently in the cytoplasm without integrating into the host genome ([@bib13]). SeVdp vectors enable a long-term expression of multiple genes from a single vector with a constant stoichiometry and do not suffer from transcriptional silencing ([@bib14]). These properties make SeVdp vectors an ideal tool for generating iPSCs. In fact, SeVdp vectors harboring four reprogramming factors (OCT4, SOX2, KLF4, and c-MYC) reprogram mouse and human somatic cells very efficiently ([@bib14; @bib15; @bib31; @bib32; @bib36]).

Here, we report the SeVdp-based stage-specific reprogramming system (3S reprogramming system) that generates paused iPSCs by controlling the KLF4 expression level with a destabilization domain (DD) and a small molecule, Shield1. We found that low KLF4 expression gives rise to partially reprogrammed cells, which are stably arrested at different stages of reprogramming depending on the level of KLF4 expression. Global gene expression analyses support that the partially reprogrammed iPSCs show intermediate gene expression profiles. Upregulation of KLF4 expression by Shield1 addition allows the partially reprogrammed cells to resume reprogramming toward pluripotency. The 3S reprogramming system establishes homogenous populations of paused iPSCs in a reproducible and predictable manner and is applicable for both mouse and human cells.

Results {#sec2}
=======

Induction of Partially Reprogrammed Cells by SeVdp Vectors {#sec2.1}
----------------------------------------------------------

In the course of developing SeVdp vectors for reprogramming, we created a vector named SeVdp(GKOSM) ([Figure 1](#fig1){ref-type="fig"}A), which is derived from SeVdp(KOSM) that induces fully reprogrammed iPSCs ([@bib14; @bib15; @bib36]). SeVdp(GKOSM) encodes EGFP in addition to KLF4, OCT4, SOX2, and c-MYC and enables monitoring of the SeVdp vector in living cells during reprogramming ([Figure S1](#app3){ref-type="sec"}A available online). Mouse embryonic fibroblasts (MEFs) infected with SeVdp(GKOSM) or SeVdp(KOSM) gave rise to almost the same number of ALP-positive (ALP^+^) colonies ([Table S1](#app3){ref-type="sec"}) consisting of small and rapidly growing cells ([Figure 1](#fig1){ref-type="fig"}B). Indeed, the colonies induced by SeVdp(GKOSM) were morphologically indistinguishable from SeVdp(KOSM)-induced ones, as exemplified by the cellular localization of β-CATENIN ([Figures 1](#fig1){ref-type="fig"}B and [S1](#app3){ref-type="sec"}B). However, the colonies induced by SeVdp(GKOSM) were negative for SSEA-1 as opposed to the ones induced by SeVdp(KOSM), which were positive for SSEA-1 ([Figure 1](#fig1){ref-type="fig"}B). Expression of *Thy1*, *Snail1*, *Snail2*, and *Tgfb3* was repressed 6 days after infection in the cells induced by SeVdp(GKOSM) and SeVdp(KOSM) ([Figure 1](#fig1){ref-type="fig"}C), consistent with the downregulation of somatic cell-specific genes at the early stage of reprogramming ([@bib26]). On the other hand, at day 49, expression of mesenchymal-specific genes such as *Cdh2*, *Zeb1*, *Zeb2*, and *Twist1* remained higher in SeVdp(GKOSM)-induced cells than in SeVdp(KOSM)-induced ones ([Figure 1](#fig1){ref-type="fig"}C), indicating that the SeVdp(GKOSM)-induced cells have not completed the mesenchymal-to-epithelial transition (MET), which normally occurs during iPSC generation ([@bib9; @bib23]). Moreover, these cells expressed only low levels of embryonic stem cell (ESC) marker genes including *Cdh1*, *Fgf4*, *Rex1* (also called *Zfp42*), and *Nanog* even at day 49 ([Figure 1](#fig1){ref-type="fig"}C), showing that they persist as partially reprogrammed cells. Independent reprogramming by SeVdp(GKOSM) yielded cells with low expression levels of *Cdh1*, *Fgf4*, and *Rex1* reproducibly ([Figure 1](#fig1){ref-type="fig"}D). Quantitative western blots ([Figure S1](#app3){ref-type="sec"}C) showed that expression of all the four reprogramming factors, especially KLF4, were lower in SeVdp(GKOSM)-infected cells than in those infected by SeVdp(KOSM) ([Figure 1](#fig1){ref-type="fig"}E), presumably because Sendai virus vectors express genes located in its 3′ region at a higher level than those in the 5′ region ([@bib34]) ([Figure 1](#fig1){ref-type="fig"}A), and the presence of the EGFP gene in the 3′ region of SeVdp(GKOSM) is detrimental for the expression of the four factors. These findings raise the possibility that lowered expression of reprogramming factors induces partially reprogrammed cells.

Low KLF4 Expression Induces Partially Reprogrammed Cells {#sec2.2}
--------------------------------------------------------

To identify which factor was responsible for partial reprogramming, we created four different vectors, SeVdp(fK-OSM), SeVdp(K-fOSM), SeVdp(KO-fSM), and SeVdp(KOS-fM). In each vector, one of the four factors was tagged N-terminally with a destabilization domain (DD), derived from a mutant FKBP12 ([@bib1]) ([Figure 2](#fig2){ref-type="fig"}A). This domain facilitates degradation of the tagged protein and decreases its expression level ([Figure 2](#fig2){ref-type="fig"}B). In addition, the DD-tagged protein is stabilized by a low molecular weight ligand, Shield1, in a precisely controlled manner ([Figure 2](#fig2){ref-type="fig"}B). When each vector was infected to MEFs in the absence of Shield1, the expression levels of DD-tagged KLF4, OCT4, SOX2, and c-MYC were 34.4% ± 6.0%, 11.5% ± 5.7%, 22.4% ± 15.8%, and 45.1% ± 14.5% of those in MEFs infected with SeVdp(KOSM), but the three other nontagged factors did not show similar decreases in expression ([Figure 2](#fig2){ref-type="fig"}C). Moreover, the expression levels of DD-tagged KLF4, OCT4, SOX2, and c-MYC in the absence of Shield1 were 34.9% ± 6.2%, 40.3% ± 20.7%, 40.5% ± 28.6%, and 46.0% ± 14.8% of those in the presence of 100 nM Shield1, but the three other nontagged factors showed lesser fluctuations in their expression levels by the addition of Shield1 ([Figure 2](#fig2){ref-type="fig"}D).

SeVdp(K-fOSM), SeVdp(KO-fSM), and SeVdp(KOS-fM) gave rise to smaller numbers of ALP^+^ colonies in the absence of Shield1 than in the presence of 100 nM Shield1 or by the infection with SeVdp(KOSM) ([Figure 2](#fig2){ref-type="fig"}E; [Table S1](#app3){ref-type="sec"}). However, these colonies in the absence of Shield1 were positive for SSEA-1 and NANOG ([Figure 2](#fig2){ref-type="fig"}F) and far more advanced in reprogramming than the SeVdp(GKOSM)-induced colonies ([Figure 1](#fig1){ref-type="fig"}B), indicating that low levels of OCT4, SOX2, and c-MYC merely reduce the efficiency of generating fully reprogrammed iPSCs. By contrast, SeVdp(fK-OSM) gave rise to similar numbers of ALP^+^ colonies as compared with SeVdp(KOSM) ([Figure 2](#fig2){ref-type="fig"}E; [Table S1](#app3){ref-type="sec"}). Moreover, the number of ALP^+^ colonies induced by SeVdp(fK-OSM) was essentially the same regardless of the presence of Shield1 ([Figure 2](#fig2){ref-type="fig"}E; [Table S1](#app3){ref-type="sec"}), and the colonies induced in the absence of Shield1 were negative for SSEA-1 and NANOG ([Figure 2](#fig2){ref-type="fig"}F), displaying a phenotype common with the SeVdp(GKOSM)-induced ones ([Figure 1](#fig1){ref-type="fig"}B). Thus, low KLF4 expression in SeVdp(GKOSM)-infected cells is the main cause of generating partially reprogrammed iPSCs, and this phenomenon can be recapitulated by SeVdp(fK-OSM) in the absence of Shield1.

To further confirm that partially reprogrammed iPSCs were induced by low KLF4 expression, we prepared vectors that express KLF4 tagged C-terminally to the PEST or CL1 degradation signal ([@bib5; @bib22]) ([Figure S2](#app3){ref-type="sec"}A). When KLF4 was tagged only with PEST \[SeVdp(Kp-OSM)\], KLF4 expression was decreased only moderately (48.0% ± 7.8%) ([Figure S2](#app3){ref-type="sec"}B), and the induced cells were not only positive for ALP ([Figure S2](#app3){ref-type="sec"}C) but also expressed ESC markers, *Cdh1*, *Fgf4*, and *Rex1* ([Figure S2](#app3){ref-type="sec"}D). Tagging KLF4 with both PEST and CL1 \[SeVdp(Kcp-OSM)\] decreased KLF4 expression slightly lower than that by SeVdp(fK-OSM) in the absence of Shield1 (23.8% ± 13.6%) ([Figure S2](#app3){ref-type="sec"}B). Indeed, SeVdp(Kcp-OSM) induced ALP^+^ colonies ([Figure S2](#app3){ref-type="sec"}C) that did not express ESC markers ([Figure S2](#app3){ref-type="sec"}D), indicating that the induced cells are partially reprogrammed as in the case of SeVdp(fK-OSM) ([Figures 2](#fig2){ref-type="fig"}E and 2F). However, removal of KLF4 \[SeVdp(OSM)\] resulted in a drastically reduced number of colonies ([Figure S2](#app3){ref-type="sec"}C). These results show that partially reprogrammed iPSCs are generated by low KLF4 expression and not by the untoward effect by the tagged DD.

Different Levels of KLF4 Expression Reprogram Cells to Different Degrees {#sec2.3}
------------------------------------------------------------------------

We next examined if iPSCs generated by SeVdp(fK-OSM) acquire pluripotency when KLF4 expression is increased by Shield1. When SeVdp(fK-OSM) was infected to MEFs in the presence of 100 or 200 nM Shield1, the KLF4 expression level was restored almost to that by SeVdp(KOSM) ([Figure 3](#fig3){ref-type="fig"}A), which generates iPSCs that contribute to mouse chimeras ([@bib14]). Expression analyses showed that cells induced by SeVdp(fK-OSM) in the presence of 100 nM Shield1 expressed the 12 marker genes in analogous time courses to those induced by SeVdp(KOSM) ([Figure 3](#fig3){ref-type="fig"}B). By contrast, the cells induced by SeVdp(fK-OSM) in the absence of Shield1 failed to completely downregulate MET-related genes and to upregulate ESC marker genes, displaying gene expression patterns similar to SeVdp(GKOSM)-induced cells ([Figures 1](#fig1){ref-type="fig"}C and [3](#fig3){ref-type="fig"}B). As in the case of the colonies induced by SeVdp(GKOSM), the expression and localization of β-CATENIN in SeVdp(fK-OSM)-induced colonies were indistinguishable from those in SeVdp(KOSM)-induced ones ([Figure S1](#app3){ref-type="sec"}B). Importantly, addition of Shield1 to the cells induced by SeVdp(Kcp-OSM) was not accompanied by the expression of the ESC-specific marker genes ([Figure S2](#app3){ref-type="sec"}D), showing that Shield1 itself has no effect on induction of pluripotency.

These iPSCs, induced in the presence of 100 nM Shield1, were easily cleared of the SeVdp(fK-OSM) genome by an small interfering RNA (siRNA) against the *L* gene ([@bib14]) that encodes the viral polymerase ([Figures 2](#fig2){ref-type="fig"}A and [3](#fig3){ref-type="fig"}C), confirming that they have acquired a self-sustaining pluripotency state. When injected into mouse blastocysts, the vector-free iPSCs (Sh100-36) contributed to mouse chimeras, which subsequently gave rise to a live pup (236-18-3) carrying the *Nanog*-GFP transgene ([Figure 3](#fig3){ref-type="fig"}D). Thus, in the presence of 100 nM Shield1, DD-tagged KLF4 functions indistinguishably from nontagged KLF4 and permits SeVdp(fK-OSM) to reprogram MEFs to acquire pluripotency.

We then used SeVdp(fK-OSM) and different concentrations of Shield1 to analyze the dose-dependent effect of KLF4 on the reprogramming process. Infection of MEFs with SeVdp(fK-OSM) in the presence of 10, 30, or 100 nM Shield1 increased the KLF4 level in a dose-dependent manner while maintaining the expression of OCT4, SOX2, and c-MYC essentially unchanged ([Figure 3](#fig3){ref-type="fig"}E). In the presence of 10 or 30 nM Shield1, SeVdp(fK-OSM) gave rise to reprogrammed cells, most of which expressed SSEA-1, but not NANOG. The reprogramming of these cells is more advanced than ALP^+^, SSEA-1-negative (SSEA-1^−^), NANOG^−^ cells induced by SeVdp(fK-OSM) in the absence of Shield1 but less advanced than ALP^+^, SSEA-1^+^, NANOG^+^ cells induced by SeVdp(fK-OSM) in the presence of 100 nM Shield1 ([Figure 3](#fig3){ref-type="fig"}F) or by SeVdp(KOSM) ([Figure 2](#fig2){ref-type="fig"}F). The intermediate degree of reprogramming is also supported by the expression levels of *Cdh1*, *Fgf4*, and *Rex1* ([Figure 3](#fig3){ref-type="fig"}G).

It is of note that independently performed reprogramming by SeVdp(fK-OSM) yielded cells with similar expression profiles of *Cdh1*, *Fgf4*, and *Rex1* ([Figure S3](#app3){ref-type="sec"}A), showing that generation of partially reprogrammed iPSCs by SeVdp(fK-OSM) is, by and large, reproducible in independent experiments. Moreover, in the presence or absence of 10 nM Shield1, individual colonies isolated from the same plate showed similar gene expression profiles of *Cdh1* and *Fgf4* ([Figure S3](#app3){ref-type="sec"}B), showing that SeVdp(fK-OSM)-induced colonies in the same plate are relatively homogeneous. Although *Rex1* was expressed at somewhat varied levels, between 2% and 30% of the miPSC level, in the independent clones induced in the presence of 10 nM Shield1, this may reflect the intrinsically heterogeneous expression of *Rex1* in mouse ESCs ([@bib35]). Together, these results demonstrate that low KLF4 expression arrests the reprogramming process prematurely, and SeVdp(fK-OSM) yields partially reprogrammed iPSCs arrested at distinct stages depending on the amount of added Shield1. Given these unique properties, we named this as SeVdp-based stage-specific reprogramming system (3S reprogramming system).

Upregulation of KLF4 Expression Allows Partially Reprogrammed iPSCs to Resume Reprogramming {#sec2.4}
-------------------------------------------------------------------------------------------

We addressed whether the partially reprogrammed cells have arrested but remained on a path toward pluripotency or have diverted from the path and become aberrantly reprogrammed. After MEFs were infected by SeVdp(fK-OSM) in the absence of Shield1 for 17 days, 100 nM Shield1 was added to the cell culture ([Figure 4](#fig4){ref-type="fig"}A). This increased the expression of DD-tagged KLF4 by more than 3-fold ([Figure 4](#fig4){ref-type="fig"}B), as revealed by anti-FKBP12 and anti-KLF4 antibodies. The upregulation of KLF4 expression at day 17 caused a gradual increase in the expression of ESC markers, NANOG ([Figure 4](#fig4){ref-type="fig"}C), *Cdh1*, *Fgf4*, and *Rex1* ([Figure 4](#fig4){ref-type="fig"}D), indicating that the cells resumed reprogramming toward pluripotency. Similarly, partially reprogrammed cells, initially induced by SeVdp(fK-OSM) in the presence of 10 or 30 nM Shield1, also showed a gradual increase in the expression of NANOG upon addition of 100 nM Shield1 ([Figure S4](#app3){ref-type="sec"}). Thus, the partially reprogrammed iPSCs generated by the 3S reprogramming system are competent to resume reprogramming upon the increased KLF4 level and hence should be regarded as "paused iPSCs."

Next, we asked if the paused iPSCs are stable and retain the ability to resume reprogramming after a long period of cell culture. We induced partially reprogrammed cells using SeVdp(fK-OSM) in the absence of Shield1, and individual clones were isolated at day 20 and cultured for additional 30 days under the same condition ([Figure 4](#fig4){ref-type="fig"}E). Even after additional culture for 30 days (between day 20 and 50), the cloned cells, Sh0-2 and Sh0-5, remained negative for SSEA-1 ([Figure 4](#fig4){ref-type="fig"}F) as well as for *Cdh1*, *Fgf4*, and *Rex1* ([Figure 4](#fig4){ref-type="fig"}G). Moreover, addition of 100 nM Shield1 at day 50 allowed the cells to resume reprogramming and to express SSEA-1 ([Figure 4](#fig4){ref-type="fig"}F) as well as *Cdh1*, *Fgf4*, and *Rex1* ([Figure 4](#fig4){ref-type="fig"}G), in similar time courses to those observed for the cells to which 100 nM Shield1 was added at day 17 ([Figure 4](#fig4){ref-type="fig"}D).

To further confirm that increased expression of KLF4, but not other Shield1-induced genes, allowed the partially reprogrammed cells to resume reprogramming, we used retrovirus-mediated gene transfer to introduce KLF4, OCT4, SOX2, or c-MYC into the paused iPSCs generated by SeVdp(fK-OSM) in the absence of Shield1. As shown in [Figure 4](#fig4){ref-type="fig"}H, additional expression of KLF4, but not other reprogramming factors, caused the cells to express SSEA-1 to a similar extent to the iPSCs generated by SeVdp(fK-OSM) in the presence of 100 nM Shield1, suggesting that the cells resume reprogramming even when KLF4 is provided by retrovirus-mediated gene transfer. Together, these results show that the paused iPSCs generated by the 3S reprogramming system are relatively stable and retain the ability to resume reprogramming for over a month.

Global Gene Expression Analyses of Paused iPSCs {#sec2.5}
-----------------------------------------------

To further characterize the paused iPSCs, we performed the analysis of their global gene expression. Hierarchical clustering of cells using differently expressed genes (DEGs) between MEFs and mouse iPSCs (miPSCs) ([@bib14]) showed that SeVdp(fK-OSM)-induced cells are more similar to miPSCs than MEFs, and the cells are clustered together according to the amount of added Shield1 ([Figure 5](#fig5){ref-type="fig"}A). Global gene expression profiles also corroborate that the paused iPSCs generated in the absence of Shield1 are stable (Sh0 22d and Sh0 79d, [Figure 5](#fig5){ref-type="fig"}A) and resume reprogramming upon the addition of 100 nM Shield1 (Sh0→100 79d, [Figure 5](#fig5){ref-type="fig"}A). Principal component analysis indicates that SeVdp(fK-OSM)-induced cells have paused at intermediate stages between MEFs and miPSCs, and that the addition of a higher amount of Shield1 reprograms the cells closer to miPSCs ([Figure S5](#app3){ref-type="sec"}A). The analysis also showed that the paused iPSCs generated by SeVdp(fK-OSM) in the absence of Shield1 resume reprogramming and advance toward pluripotency upon the addition of 100 nM Shield1 ([Figure S5](#app3){ref-type="sec"}B). A recent study reported that mesendodermal genes are transiently activated during reprogramming and subsequently repressed again in iPSCs ([@bib30]). Consistent with this, paused iPSCs express some of the mesendodermal genes (*Eomes*, *Mixl1*, and *T*), which are nonetheless repressed in fully reprogrammed iPSC produced by SeVdp(KOSM) or SeVdp(fK-OSM) in the presence of 100 nM Shield1 ([Figures S5](#app3){ref-type="sec"}C--S5E). These gene expression profiles again confirm that paused iPSCs are intermediates during reprogramming.

Hierarchical clustering of DEGs also revealed the presence of five distinct gene groups ([Figure 5](#fig5){ref-type="fig"}B). Group D includes a set of genes whose expression is already downregulated in paused iPSCs (Sh0 22d). The genes in groups A and B increase expression in a stepwise manner from MEFs to paused iPSCs (Sh0 22d) and from paused iPSCs (Sh0 22d) to iPSCs (Sh100 22d), respectively. Pathway analysis shows that Podocyte-related genes, which are involved in the epithelial-to-mesenchymal transition (EMT) of podocytes, are enriched in groups A and D ([Figure 5](#fig5){ref-type="fig"}C), indicating that the mesenchymal-to-epithelial transition (MET), a reverse process of EMT, separates paused iPSCs (Sh0 22d) from MEFs. This result is consistent with a previous report that showed the important role for KLF4 in MET during reprogramming ([@bib9]). Furthermore, PluriNetWork genes, which are associated with pluripotency, are enriched in groups A and B ([Figure 5](#fig5){ref-type="fig"}C), and heatmaps show that all the PluriNetWork genes in groups A and B increase their expression in a Shield1-dependent manner ([Figure 5](#fig5){ref-type="fig"}D), as if increasing the amount of KLF4 recapitulates the chronological progression of reprogramming. Independent quantitative RT-PCR analysis of selected pluripotency-related genes ([@bib8; @bib16; @bib38]) identified two categories of genes that show distinct expression profiles in response to the Shield1 amount; genes that increase expression gradually as the amount of Shield1 is increased (upper panel, [Figures 5](#fig5){ref-type="fig"}E and [S5](#app3){ref-type="sec"}F--S5M) and genes that increase expression markedly at 30 nM or higher concentrations of Shield1 (lower panel, [Figures 5](#fig5){ref-type="fig"}E and [S5](#app3){ref-type="sec"}N--S5U). The former and the latter categories of genes correspond more or less to the genes in group A and group B, respectively ([Figures 5](#fig5){ref-type="fig"}D and 5E), demonstrating that pluripotency-related genes respond to the KLF4 level by at least two distinguishable modes. Together, the global gene expression analyses indicate that the iPSCs generated by the 3S reprogramming system are paused at critical stages of reprogramming and suggest that the KLF4-dependent transitions from one stage to the next is accompanied by changes in the expression of genes that are crucial for reprogramming.

Generation of Partially Reprogrammed Human iPSCs {#sec2.6}
------------------------------------------------

Although molecular mechanisms of mouse iPSC generation have been investigated substantially, there have been relatively few mechanistic analyses of human iPSCs. Because our SeVdp vectors have been used successfully to generate human iPSCs from various somatic cells ([@bib15; @bib31; @bib32; @bib36]), we tested if the 3S reprogramming system generates human iPSCs that have paused during reprogramming. When SeVdp(KOSM) and SeVdp(GKOSM) were infected to human fibroblasts, both vectors produced ALP^+^ colonies of small, rapidly growing cells in a similar manner to MEFs, although SeVdp(GKOSM) induced slightly more colonies than SeVdp(KOSM) ([Figure 6](#fig6){ref-type="fig"}A; [Table S1](#app3){ref-type="sec"}). SeVdp(GKOSM)-induced human cells are similar to their mouse counterparts ([Figure 1](#fig1){ref-type="fig"}B) in that they are positive for ALP but negative for ESC markers, *CDH1*, *FGF4*, and *REX1* ([Figure 6](#fig6){ref-type="fig"}B).

When human fibroblasts were infected with SeVdp(fK-OSM) in the presence or absence of 100 nM Shield1, similar numbers of ALP^+^ colonies were obtained regardless of the presence of Shield1 ([Figure 6](#fig6){ref-type="fig"}A; [Table S1](#app3){ref-type="sec"}). However, induction in the absence of Shield1 generated cells that were negative for *CDH1*, *FGF4*, and *REX1*, whereas induction in the presence of 100 nM Shield1 generated cells that expressed these ESC marker genes ([Figure 6](#fig6){ref-type="fig"}B). Moreover, as in the case of mouse iPSCs ([Figure 3](#fig3){ref-type="fig"}C), hiPSCs generated by SeVdp(fK-OSM) in the presence of 100 nM Shield1 were cleared of the vector by the siRNA against the *L* gene to establish vector-free hiPSCs ([Figure S6](#app3){ref-type="sec"}). These results indicate that SeVdp(fK-OSM) generates partially reprogrammed human iPSCs that are similar to the paused mouse iPSCs as well as fully reprogrammed iPSCs that have acquired a self-sustaining pluripotency state. Thus, the 3S reprogramming system can be utilized to generate partially reprogrammed human iPSCs, and these cells will be useful for analyzing the mechanism of human iPSC generation.

Discussion {#sec3}
==========

Understanding the mechanisms of iPSC generation is important for application for cell therapy and also provides insights into the molecular mechanisms of normal developmental processes. The analysis, however, suffers from technical limits because the intermediate cells in the process of reprogramming are transient, asynchronous and heterogeneous. Cell sorting enriches intermediate cells, but they are transient and limited in amount ([@bib6; @bib16; @bib20]). For example, SSEA-1^+^ Oct4^−^ reprogramming intermediates, initially isolated by fractionation using SSEA-1 antigen, diversify into a heterogeneous population of cells upon continued cell culture; some of them revert to lose SSEA-1 expression, whereas others advance to initiate Oct4 expression ([@bib20]). Partially reprogrammed cell populations obtained during iPSC generation are relatively stable and expandable, but they are usually sporadic and unpredictable byproducts of reprogramming ([@bib10; @bib24]), sometimes generating aberrantly reprogrammed cells that do not transit into the pluripotent state ([@bib10]).

Unlike these previous methods, the 3S reprogramming system generates partially reprogrammed iPSCs in a reproducible and predictable manner by regulating the amount of KLF4. These cells resume reprogramming upon increased KLF4 expression and therefore are not aberrantly reprogrammed but have paused during iPSC generation. Different KLF4 levels yield paused iPSCs at a series of stages during iPSC generation, enabling the molecular analysis of orderly events that proceed during reprogramming. Moreover, the paused iPSCs are relatively homogeneous and phenotypically stable, allowing expansion of cells for further analyses. Last, this system is based upon a defective Sendai virus, which replicates exclusively in the cytoplasm ([@bib14]), and thus is free from both the positional effects and the silencing of transgenes that may arise in the systems based upon the retrovirus or lentivirus ([@bib7]). Therefore, our system to generate paused iPSCs is a significant advance over the sorted cells and partially reprogrammed cell populations previously used for mechanistic analyses of iPSC generation.

It remains to be determined how the low expression of KLF4, but not the other three factors, generates paused iPSCs. It is known that KLF4 represses somatic gene expression together with c-MYC at an early stage of iPSC generation and enhances pluripotency gene expression in cooperation with OCT4 and SOX2 at its late stage ([@bib20]). Therefore, reduced levels of KLF4 may be sufficient for repressing somatic cell-specific genes, but not for activating pluripotency-related genes. A recent study also showed that KLF4 organizes long-range chromosomal interactions with the *Oct4* locus by recruiting cohesion ([@bib37]). These chromosomal interactions are observed not in SSEA-1^−^ cells but only in SSEA-1^+^ cells during reprogramming, suggesting that KLF4 may mediate the chromosomal reorganization during the transition from the SSEA-1^−^ to SSEA-1^+^ cells. Interestingly, this corresponds to a stage where SeVdp(fK-OSM) generates paused iPSCs in the absence of Shield1. It is thus possible that such dynamic chromosomal reorganization requires a high level of KLF4 and presents a roadblock for reprogramming with a low expression level of KLF4.

Recently, Sui et al. reported production of partially reprogrammed iPSCs using trimethoprim (TMP)-regulated destabilizing domain to control the expression of reprogramming factors from a *piggyBac* transposon vector ([@bib27]). In contrast to our 3S reprogramming system, SOX2 rather than KLF4 plays a predominant role in regulating the progression of reprogramming. Several reasons may account for this apparent discrepancy. First, each system employed a different combination of the vector and reprogramming factors for iPSC generation. Sui et al. used only OCT4, SOX2, and KLF4 in *piggyBac* transposon vectors whereas our system used OCT4, SOX2, KLF4, and c-MYC in SeVdp vectors. Second, unlike the FKBP-based domain used in our system, the destabilizing domain used by Sui et al. seems to promote more complete protein degradation. Third, reprogramming may proceed via distinct pathways in each system and therefore the role for each reprogramming factor may not be identical between different systems. In fact, recent studies indicate the presence of multiple pathways by which reprogramming proceeds toward pluripotency ([@bib16; @bib19; @bib21]). Given this possibility, the availability of different systems that may generate iPSCs stalled at alternative intermediate states should be invaluable for more comprehensive understanding of the reprogramming process.

Regardless of the effect of the KLF4 expression level on the progression of reprogramming, the 3S reprogramming system described here provides a powerful tool for analyzing the mechanism of iPSC generation, particularly with respect to its ill-defined intermediate stages. One such example is MET, a reverse process of EMT that occurs during normal development. Consistent with the role for KLF4 in MET ([@bib9]), the paused iPSCs generated in the absence of Shield1 have stalled around MET and show gene expression profiles reminiscent of the ongoing MET. Another is the primitive streak-like mesendodermal (PSMN) state, where cells transiently display gene expression profiles resembling mesendoderm ([@bib30]), which forms part of the primitive streak during early embryonic development. Paused iPSCs generated in the presence of 10--30 nM Shield1 express mesendoderm-related genes but have not reached the fully reprogrammed state. Because the addition of Shield1 permits the paused iPSCs to advance toward the fully reprogrammed state in a controlled manner, the 3S reprogramming system may be especially suitable for analyzing the MET stage, the mesendodermal stage as well as the late stage toward pluripotency. Finally, in addition to MEF-based iPSC generation, the current system also works for human somatic cells. Thus, the 3S reprogramming system will offer a unique opportunity to analyze transient and unstable stages of iPSC generation from mouse and human somatic cells.

Experimental Procedures {#sec4}
=======================

Cell Culture and Generation of iPSCs {#sec4.1}
------------------------------------

Mouse iPSCs were generated from mouse embryonic fibroblasts (MEFs) isolated from a transgenic mouse carrying the *Nanog*-GFP-IRES-Puro^r^ reporter construct ([@bib17]) (provided by the RIKEN BioResource Center) (*Nanog*-GFP MEFs). After *Nanog*-GFP MEFs were infected with each SeVdp vector at 32°C for 14 hr at an MOI of about 5, 2.0 × 10^4^ of infected cells were seeded onto mitomycin C-treated MEFs in 6-well plates and cultured in KSR medium (Knockout-DMEM (Life Technologies) supplemented with 15% Knockout Serum Replacement (Life Technologies), 2 mM GlutaMAX (Life Technologies), 0.1 mM nonessential amino acids (Life Technologies), 55 μM 2-mercaptoethanol (Life Technologies), 100 U/ml penicillin-streptomycin (Wako), and 1,000 U/ml LIF \[Wako\]) for 7 days, and then in mES medium (DMEM; nacalai tesque) supplemented with 15% fetal bovine serum (Hyclone), 0.1 mM nonessential amino acids, 55 μM 2-mercaptoethanol, 100 U/ml penicillin-streptomycin and 1,000 U/ml LIF), in the presence or absence of Shield1 (Takara Bio). The presence of the vector in MEFs was confirmed 1 day after infection by immunostaining using an anti-SeV NP monoclonal antibody ([@bib14]) as described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}. Reprogrammed cells were maintained on mitomycin C-treated SNL76/7 feeder cells (DS Pharma Biomedical) in the same mES medium, which was changed every 2 days. To remove SeVdp vectors from the reprogrammed cells, the cells were treated with 40 nM of L527 siRNA ([@bib14]) mixed with Lipofectamine RNAi MAX Transfection Reagent (Life Technologies) in every passage after about day 20.

Human iPSCs were generated from human skin fibroblast NB1RGB cells (RIKEN BioResource Center). The cells were infected with SeVdp vectors at room temperature for 2 hr followed by 37°C for 14 hr at an MOI of about 5, and 2.0 × 10^4^ of infected cells were seeded onto mitomycin C-treated MEFs in 6-well plates and cultured in Primate ESC culture medium (ReproCell) with 5 ng/ml basic FGF (Wako).

Retroviral vectors were infected to partially reprogrammed Sh0-5 cells cultured under a feeder-free condition at an MOI of about 10 for 2 days with 8 μg/ml of Hexadimethrine bromide (polybrene; Sigma). The cells were then passaged onto feeder cells and cultured in mES medium.

Determination of Protein Expression by Western Blotting {#sec4.2}
-------------------------------------------------------

After SeVdp vectors were infected to MEFs, the cells were collected one day after infection and lysed on ice in SDS-PAGE gel loading buffer (50 mM Tris-HCl \[pH 6.8\], 2% SDS, 10% glycerol, 0.1 mg/ml Bromophenol blue, 5% 2-mercaptoethanol), followed by boiling for 5 min, and the whole-cell extracts were subjected to western blot analysis. Antibodies against SOX2, KLF4 or c-MYC were prepared by immunizing rabbits with each purified recombinant protein, as described previously ([@bib4]). Each full-length recombinant protein was expressed in BL21(DE3)pLysS, separated by SDS-PAGE, and electroeluted. The purified recombinant proteins were used to immunize rabbits by Japan Bio Serum, and the obtained sera were affinity-purified by a corresponding antigen column, in which glutathione S-transferase (GST)-tagged proteins was crosslinked to glutathione Sepharose 4B (GE Healthcare). Anti-OCT4 (1:5,000, ab19857, Abcam) and anti-α-TUBULIN (1:10,000, ab7291, Abcam) were purchased commercially. Blots were probed with anti-rabbit or anti-mouse IgG-HRP secondary antibody (1:5,000, GE Healthcare) and visualized using Luminol, p-Coumaric acids, and H~2~O~2~ ([@bib11]). Intensity of the chemiluminescence was quantified by LAS4000 (GE Healthcare) using ImageQuant TL software (GE Healthcare). We calculated the relative protein expression level of each reprogramming factor by normalizing on the basis of α-TUBULIN protein expression as described in [Figure S1](#app3){ref-type="sec"}C. Determination of protein expression was carried out from biologically triplicate experiments.

Characterization of Mouse and Human iPSCs {#sec4.3}
-----------------------------------------

Detailed methods for immunofluorescence, ALP staining, quantitative RT-PCR, microarray analysis, and generation of chimeric mice are described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

All animal experiments were performed according to the Guide for the Care and Use of Laboratory Animals at the University of Tsukuba.

Accession Numbers {#app1}
=================

The NCBI Gene Expression Omnibus (GEO) accession number for the gene expression data sets reported in this paper is [GSE56406](ncbi-geo:GSE56406){#intref0010}.

Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S6, and Tables S1 and S2Document S2. Article plus Supplemental Information
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![Generation of Partially Reprogrammed iPSCs by SeVdp Vectors\
(A) Structures of SeVdp(KOSM) and SeVdp(GKOSM).\
(B) Expression of ESC markers. Colonies induced by SeVdp(KOSM) or SeVdp(GKOSM) were stained for ALP or SSEA-1 at day 10 or 18, respectively. Scale bars, 100 μm.\
(C) Time course of mRNA expression. Cells were collected at day 0, 6, 13, 25, and 49, and the mRNA levels of indicated genes were determined by quantitative RT-PCR and plotted relative to those in MEFs or mouse iPSCs (miPSC) ([@bib14]). Data represent means ± SEM of three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus SeVdp(KOSM)-infected cells.\
(D) Reproducibility of reprogramming by SeVdp(GKOSM). Cells were collected at day 25 (Exp. 1) or day 23 (Exp. 2 and 3), and the mRNA levels of *Cdh1*, *Fgf4*, and *Rex1* were determined by quantitative RT-PCR. Data represent means ± SEM of three independent PCR reactions. n.s., not significant; ^∗∗∗^p \< 0.001 versus Exp. 1.\
(E) Protein levels of reprogramming factors expressed from SeVdp vectors. SeVdp(KOSM) or SeVdp(GKOSM)-infected MEFs were collected 1 day after infection, and the protein level of each reprogramming factor was determined by western blotting as described in the [Experimental Procedures](#sec4){ref-type="sec"}. The protein level of each factor is plotted relative to that in SeVdp(KOSM)-infected cells. Data represent means ± SEM of three independent experiments. ^∗∗^p \< 0.01.\
See also [Figure S1](#app3){ref-type="sec"} and [Tables S1](#app3){ref-type="sec"} and [S2](#app3){ref-type="sec"}.](gr1){#fig1}

![Effects of Downregulated KLF4, OCT4, SOX2, or c-MYC on Reprogramming\
(A) Structures of SeVdp vectors in which one of the reprogramming factors is tagged N-terminally with DD.\
(B) Stability of DD-tagged reprogramming factor during iPSC generation is regulated by the addition of Shield1.\
(C and D) Protein levels of reprogramming factors expressed from SeVdp vectors. Cell extracts were prepared from MEFs infected with each indicated vector one day after infection in the presence or absence of 100 nM Shield1. The protein level of each reprogramming factor is determined by western blotting, and the level in the absence of 100 nM Shield1 is plotted relative to that in SeVdp(KOSM)-infected cells (C) or in the presence of 100 nM Shield1 (D). Data represent means ± SEM of three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus SeVdp(KOSM) (C) or versus in the presence of 100 nM Shield1 (D).\
(E) ALP^+^ colonies induced by each vector. MEFs (1.0 × 10^4^) infected with the indicated vector were cultured in the presence or absence of 100 nM Shield1 and stained for ALP at day 13.\
(F) Expression of SSEA-1 and NANOG. SSEA-1 was detected by immunofluorescence staining at day 18, and NANOG was detected by GFP fluorescence from the *Nanog*-GFP reporter transgene at day 22. Scale bars, 100 μm.\
See also [Figure S2](#app3){ref-type="sec"} and [Table S1](#app3){ref-type="sec"}.](gr2){#fig2}

![iPSC Generation by Manipulating the Protein Level of Exogenous KLF4\
(A) Protein levels of reprogramming factors expressed from SeVdp(fK-OSM). Cell extracts were prepared from MEFs infected with SeVdp(fK-OSM) in the presence of the indicated concentration of Shield1 for one day. Protein levels are plotted relative to those in SeVdp(KOSM)-infected cells. Data represent means ± SEM of three independent experiments. ^∗∗^p \< 0.01 versus SeVdp(KOSM).\
(B) Time course of mRNA expression. SeVdp(fK-OSM)- or SeVdp(KOSM)-infected cells cultured in the presence (Sh100) or absence (Sh0) of 100 nM Shield1 were collected at days 7, 13, and 27 for quantitative RT-PCR. Data represent means ± SEM of three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01 versus SeVdp(KOSM)-infected cells.\
(C) Vector-free iPSCs generated by SeVdp(fK-OSM). The cells induced by SeVdp(fK-OSM) in the presence of 100 nM of Shield1 (P3) were treated three times with L527 siRNA (P7), and the vector-free iPSCs were isolated at day 50 (Sh100-36 and Sh100-43). Green, *Nanog*-GFP. Red, NP of SeV. Scale bars, 100 μm.\
(D) Production of chimeras from iPSCs established by SeVdp(fK-OSM) to show germline transmission. Genomic DNAs of the chimeric mice generated by the microinjection of clone Sh100-36 or Sh100-43, and their pups were analyzed by PCR to detect the *Nanog*-GFP transgene. The IL-2 gene was amplified as an internal control.\
(E) Gradual increase of KLF4 expression by Shield1. Cell extracts were prepared as in (A). Protein levels are plotted relative to those in SeVdp(KOSM)-infected cells. Data represent means ± SEM of three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01.\
(F) Expression of SSEA-1 (day 27) and NANOG (day 29) in the cells cultured at indicated concentrations of Shield1. Scale bars, 100 μm.\
(G) The *Cdh1*, *Fgf4*, and *Rex1* mRNA levels were determined by quantitative RT-PCR at days 7, 13, and 27 for SeVdp(fK-OSM)-infected cells cultured at indicated concentrations of Shield1. Data represent means ± SEM of three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus SeVdp(fK-OSM) in the absence of Shield1.\
See also [Figures S1](#app3){ref-type="sec"} and [S3](#app3){ref-type="sec"} and [Table S2](#app3){ref-type="sec"}.](gr3){#fig3}

![Upregulation of Exogenous KLF4 Resumes Reprogramming\
(A) Outline of the experiments to restart reprogramming in partially reprogrammed iPSCs generated by SeVdp(fK-OSM) through the addition of Shield1 at day 17.\
(B) Upregulation of the DD-tagged KLF4 protein level in partially reprogrammed iPSCs after 5 days of Shield1 addition. The protein levels of DD-tagged KLF4 or total KLF4 was determined by western blotting using an anti-FKBP or anti-KLF4 antibody, respectively, and were plotted relative to those in the cells cultured in the absence of Shield1. Data represent means ± SEM of three independent experiments. ^∗^p \< 0.05.\
(C) GFP fluorescence of the *Nanog*-GFP transgene was observed at indicated time points. Scale bars, 100 μm.\
(D) The *Cdh1*, *Fgf4*, and *Rex1* mRNA levels were determined by quantitative RT-PCR at day 16, 27, 36, and 49. 100 nM Shield1 was added at day 17. Data represent means ± SEM of three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01 versus no addition of Shield1.\
(E) Partially reprogrammed iPSC clones were isolated at day 20 (Sh0-2 and Sh0-5) and cultured in the absence of Shield1 until day 50, when Shield1 was added.\
(F) SSEA-1 expression was analyzed at indicated time points. Scale bars, 100 μm.\
(G) Clone Sh0-5 was cultured in the absence of Shield1 until day 50, when Shield1 was added. The mRNA levels of *Cdh1*, *Fgf4*, and *Rex1* were determined at day 31, 45, 64, 73, and 100. Data represent means ± SEM of three independent experiments. ^∗^p \< 0.05 versus no addition of Shield1.\
(H) SSEA-1 expression was analyzed in paused iPSCs (Sh0-5) 29 days after the addition of 100 nM Shield1 or infection with a retroviral vector expressing KLF4, OCT4, SOX2, or c-MYC. Scale bars, 100 μm.\
See also [Figure S4](#app3){ref-type="sec"} and [Table S2](#app3){ref-type="sec"}.](gr4){#fig4}

![Global Gene Expression Profiles of Paused iPSCs\
(A) Hierarchical clustering of paused iPSCs based on gene expression profiles of the differentially expressed genes (DEGs) between MEFs and miPSCs (p \< 0.05). Analyzed samples include cells induced by SeVdp(fK-OSM) at the indicated concentrations (0, 10, 30, or 100 nM) of Shield1 for 22 or 79 days. Cells that resumed reprogramming (Sh0→100 79d) were first induced by SeVdp(fK-OSM) in the absence of Shield1 for 25 days and then cultured in the presence of 100 nM Shield1 before collection at day 79.\
(B) Hierarchical clustering of DEGs. DEGs between MEFs and miPSCs (p \< 0.05) were clustered based on gene expression profiles of the indicated cells and classified into five groups (group A--E).\
(C) Enriched pathways in the genes of groups A, B, or D.\
(D) Heatmap of the expression profiles of PluriNetWork genes clustered in group A or B.\
(E) Two distinct expression profiles of pluripotency-related genes at increasing concentrations of Shield1. SeVdp(fK-OSM)-infected cells were cultured in the presence of indicated concentrations of Shield1, and the cells were collected at day 27. The mRNA levels of pluripotency-related genes were determined by quantitative RT-PCR. Data represent mean ± SEM of three independent experiments.\
See also [Figure S5](#app3){ref-type="sec"} and [Table S2](#app3){ref-type="sec"}.](gr5){#fig5}

![Generation of Partially Reprogrammed iPSCs from Human Somatic Cells\
(A) Generation of ALP^+^ human iPSCs by SeVdp(fK-OSM). The indicated SeVdp vectors were used to generate human iPSCs, and the cells were stained for ALP at day 16. Scale bars, 100 μm.\
(B) Expression of ESC markers in partially reprogrammed human iPSCs. The mRNA levels of *CDH1*, *FGF4*, and *REX1* in the cells infected by the indicated vector in the presence or absence of 100 nM Shield1 were determined by quantitative RT-PCR at day 18. Data represent means ± SEM of three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01 versus SeVdp(KOSM)-infected cells.\
See also [Figure S6](#app3){ref-type="sec"} and [Tables S1](#app3){ref-type="sec"} and [S2](#app3){ref-type="sec"}.](gr6){#fig6}
